BioCentury
ARTICLE | Company News

Mauna Kea, University of Edinburgh, University of Utah deal

December 3, 2012 8:00 AM UTC

Mauna Kea partnered with the University of Edinburgh to add molecular imaging capabilities to Mauna Kea's Cellvizio optical biopsy device for diagnosing and monitoring patients with pulmonary diseases. The partners will develop the university's clinical-grade molecular imaging Smartprobes, which selectively generate fluorescent signals that can be imaged using the company's Cellvizio product. Both parties will retain rights to their respective IP under the deal, which will focus on intensive-care patients with inflammatory lung disease. The company declined to disclose details. ...